GLUE SG&A Expense Growth
Monte Rosa Therapeutics Inc · SG&A Expense Growth
GLUE SG&A Expense Growth
Latest reported3.44%period ending
GLUE FY SG&A Growth (YoY) (0.00% → 3.44%)
Latest values, visible window
High-resolution chart · PNG
GLUE sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.4375% | |
| 9.7756% | |
| 17.2602% | |
| 73.7331% | |
| 292.6841% | |
| 521.8944% | |
| 0% |